Feinsod Matthew 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed May 15, 2019
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Common Stock
2019-05-13+2,000→ 54,014 total - Tax Payment
Common Stock
2019-05-13$4.20/sh−685$2,877→ 53,329 total
Footnotes (1)
- [F1]The common stock vested immediately upon grant.